With the analysis among 6,211 patents, we discovered top 474 key players by total patent application. Pfizer Inc., Bayer Pharma AG, Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA are dominant in this area. They take 14.35% of the total patent filing.
New York, United States
Patent: 351
Berlin, Germany
Patent: 271
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA
F. Hoffmann-La Roche Ltd.
Memory Pharmaceuticals Corp.
New Jersey, United States
Patent: 145
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 128
Hounslow, United Kingdom
Patent: 122
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 112
Biosplice Therapeutics, Inc.
California, United States
Patent: 111
With the analysis among 156 patents, we discovered top 12 start-ups by total patent application. Biosplice Therapeutics, Inc., ESCAPE Bio, Inc., Bold Therapeutics, Inc. are active in this area.
Biosplice Therapeutics, Inc.
California, United States
Patent: 113
California, United States
Patent: 17
British Columbia, Canada
Patent: 10
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 4
Massachusetts, United States
Patent: 3
Disarm Therapeutics, Inc.
Massachusetts, United States
Patent: 3
Texas, United States
Patent: 1
Institut National de la Santé et de la Recherche Médicale
With the analysis among related 974 patents applied in the last 5 years. We discover 255 most active companies in this area. The fast-growing FMC Corp., Pfizer Inc., Bristol Myers Squibb Co. take 12.11% of patent filing during this period.
Pennsylvania, United States
Patent: 43
New York, United States
Patent: 39
New York, United States
Patent: 36
New Jersey, United States
Patent: 27
Biosplice Therapeutics, Inc.
California, United States
Patent: 24
Berlin, Germany
Patent: 22
Massachusetts, United States
Patent: 22
Basel-Stadt, Switzerland
Patent: 20
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 19
With the analysis among related 974 patents in last 5 years, we discover 186 new entrants. Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., ESCAPE Bio, Inc. are the most active new entrants in this area.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 19
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 19
California, United States
Patent: 17
Massachusetts, United States
Patent: 13
Massachusetts, United States
Patent: 13
Corcept Therapeutics, Inc.
California, United States
Patent: 12
Connecticut, United States
Patent: 12
California, United States
Patent: 10
Sunshine Lake Pharma Co. Ltd.
Guangdong Sheng, China
Patent: 10
First Bio Therapeutics Co. Ltd.
With the analysis among 463 patents, we discovered top 110 universities and scientific research institutions by total patent application. Council of Scientific & Industrial Research, Vanderbilt University, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 14.04% of the total patent filing.
Council of Scientific & Industrial Research
Tennessee, United States
Patent: 19
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 16
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 13
Sichuan Sheng, China
Patent: 11
Korea Institute of Science & Technology
Massachusetts, United States
Patent: 10
Sichuan Sheng, China
Patent: 10
Gwangju Institute of Science & Technology
Henan Sheng, China
Patent: 8